<DOC>
	<DOCNO>NCT01735331</DOCNO>
	<brief_summary>The aim study determine vascular endothelial growth factor level angiogenesis/vascularity hysteroscopic endometrial biopsy take patient Recurrent Pregnancy Loss.The endometrial vascular endothelial growth factor level measure immunohistochemical staining method due office hysteroscopic endometrial biopsy menstruation follicular phase menstrual cycle .</brief_summary>
	<brief_title>Vascular Endothelial Growth Factor Levels Hysteroscopic Biopsies Which Taken From Recurrent Pregnancy Loss</brief_title>
	<detailed_description>This study prospective , observational , single-center study.Ethical approval obtain Institutional Review Board.This study complete 30 patient Habitual Abortus . Endometrial vascular endothelial growth factor level measure use Flk-1 / Kinase Domain Receptor / Vascular endothelial growth factor receptor-2 , Ab-1 ( Rabbit PAb ) , Vascular Endothelial Growth Factor ( VEGF ) Ab-7 ( VG1 ) , Cluster Differentiation 34 ( Endothelial Cell Marker ) Ab-1 ( QBEnd/10 ) , Vascular endothelial growth factor receptor-1 ( N-term ) ( FLT1 ) antibody kit . All assay perform accord manufacturer 's instruction .</detailed_description>
	<mesh_term>Abortion , Spontaneous</mesh_term>
	<mesh_term>Fetal Death</mesh_term>
	<mesh_term>Endothelial Growth Factors</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Patients Recurrent Pregnancy Loss accept join study . Patients whose age &lt; 18 &gt; 45 Patients pregnancy .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Vascular endothelial growth factor , Recurrent Pregnancy Loss</keyword>
</DOC>